Similar articles for PMID: 35379713

Year	Number of Results
2016	2
2017	2
2018	8
2019	13
2020	23
2021	37
2022	49
2023	27
2024	2

1

Prescription Patterns of Novel Antihyperglycemic Medications.

Ali AS, Khan M, Ortega D, Jaffery S, Lamerato LE, Budzynska K. Ali AS, et al. J Am Board Fam Med. 2022 Mar-Apr;35(2):255-264. doi: 10.3122/jabfm.2022.02.210360. J Am Board Fam Med. 2022. PMID: 35379713 Free article.

2

Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States.

Nargesi AA, Clark C, Aminorroaya A, Chen L, Liu M, Reddy A, Amodeo S, Oikonomou EK, Suchard MA, McGuire DK, Lin Z, Inzucchi S, Khera R. Nargesi AA, et al. Am J Cardiol. 2023 Jun 1;196:89-98. doi: 10.1016/j.amjcard.2023.03.002. Epub 2023 Apr 1. Am J Cardiol. 2023. PMID: 37012183

3

Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications.

Pineda ED, Liao IC, Godley PJ, Michel JB, Rascati KL. Pineda ED, et al. J Manag Care Spec Pharm. 2020 May;26(5):610-618. doi: 10.18553/jmcp.2020.26.5.610. J Manag Care Spec Pharm. 2020. PMID: 32347181 Free PMC article.

4

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study.

Lugner M, Sattar N, Miftaraj M, Ekelund J, Franzén S, Svensson AM, Eliasson B. Lugner M, et al. Cardiovasc Diabetol. 2021 Mar 22;20(1):67. doi: 10.1186/s12933-021-01258-x. Cardiovasc Diabetol. 2021. PMID: 33752680 Free PMC article.

5

Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.

Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V. Ikonomidis I, et al. J Am Heart Assoc. 2020 May 5;9(9):e015716. doi: 10.1161/JAHA.119.015716. Epub 2020 Apr 24. J Am Heart Assoc. 2020. PMID: 32326806 Free PMC article. Clinical Trial.

6

Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.

Li CX, Liang S, Gao L, Liu H. Li CX, et al. PLoS One. 2021 Feb 19;16(2):e0244689. doi: 10.1371/journal.pone.0244689. eCollection 2021. PLoS One. 2021. PMID: 33606705 Free PMC article.

7

Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis.

Mishriky BM, Okunrintemi V, Jain S, Sewell KA, Powell JR, Cummings DM. Mishriky BM, et al. Diabetes Metab. 2021 Feb;47(1):101160. doi: 10.1016/j.diabet.2020.05.002. Epub 2020 May 18. Diabetes Metab. 2021. PMID: 32439471

8

Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction.

Trombara F, Cosentino N, Bonomi A, Ludergnani M, Poggio P, Gionti L, Baviera M, Colacioppo P, Roncaglioni MC, Leoni O, Bortolan F, Agostoni P, Genovese S, Marenzi G. Trombara F, et al. Cardiovasc Diabetol. 2023 Feb 6;22(1):26. doi: 10.1186/s12933-023-01758-y. Cardiovasc Diabetol. 2023. PMID: 36747186 Free PMC article.

9

Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials.

Patoulias D, Stavropoulos K, Imprialos K, Katsimardou A, Kalogirou MS, Koutsampasopoulos K, Zografou I, Papadopoulos C, Karagiannis A, Doumas M. Patoulias D, et al. Diabetes Res Clin Pract. 2019 Dec;158:107927. doi: 10.1016/j.diabres.2019.107927. Epub 2019 Nov 13. Diabetes Res Clin Pract. 2019. PMID: 31733280

10

Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis.

Zhuo M, Li J, Buckley LF, Tummalapalli SL, Mount DB, Steele DJR, Lucier DJ, Mendu ML. Zhuo M, et al. Kidney360. 2022 Jan 19;3(3):455-464. doi: 10.34067/KID.0007862021. eCollection 2022 Mar 31. Kidney360. 2022. PMID: 35582176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year